Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	13.19B
Revenue (ttm)	1.12B
Net Income (ttm)	151.92M
Shares Out	65.86M
EPS (ttm)	2.28
PE Ratio	87.85
Forward PE	45.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,424
Average Volume	316,318
Open	200.00
Previous Close	200.20
Day's Range	190.20 - 200.00
52-Week Range	175.60 - 402.00
Beta	0.43
RSI	53.67
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.